KristaLLentineMDPhD

Professor, Saint Louis University School of Medicine, Center for Abdominal Transplantation | Associate Division Director, Nephrology

Dr. Lentine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3660 Vista Ave
Saint Louis, MO 63110
Phone+1 314-977-8765

Fax+1 314-771-0784

Dr. Krista Lentine is a nephrologist specializing in treatment of adult patients with kidney disease. She is a world-renowned researcher who co-chaired the international work group that developed guidelines for living donor kidney transplantation.

Dr. Lentine is a professor in the Department of Internal Medicine, Division of Nephrology, at Saint Louis University School of Medicine. She is medical director of living donation at the SSM Health Transplant Center at Saint Louis University Hospital.

In 2018, Dr. Lentine received the Dr. Shaul Massry Distinguished Lecture honor from the National Kidney Foundation. Her professional memberships include the American Society of Nephrology Quality Committee and American Society of Transplantation Living Donor Community. She has served as chair of the Organ Procurement and Transplantation Network/United Network for Organ Sharing Living Donor Committee.

Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 2003 - 2004
Stanford Health Care-Sponsored Stanford UniversityFellowship, Nephrology, 2001 - 2003
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1998 - 2001
Stanford University School of MedicineClass of 1998

APOL1 Genetic Testing in African Americans Start of enrollment: 2019 Jan 24
Recruiting
Roles: Principal Investigator, Contact

PubMed

Journal Articles

Addressing Disparities in Living Donor Kidney Transplantation
Krista L Lentine, Didier Mandelbrot, Journal of the American Society of Nephrology
Induction Immunosuppression Agents as Risk Factors for Incident Cardiovascular Events and Mortality After Kidney Transplantation
Krista Lentine, Dorry L Segev, American journal of transplantation

Other

Lipid abnormalities after renal transplantation
Lentine KL, Brennan DC
http://www.uptodate.com/contents/lipid-abnormalities-after-renal-transplantation
UpToDate, Wolters Kluwer Health - 2012-10-18
Risk factors for cardiovascular disease in the renal transplant recipient
Lentine KL, Vella J
http://www.uptodate.com/contents/risk-factors-for-cardiovascular-disease-in-the-renal-transplant-rec
UpToDate, Wolters Kluwer Health - 2013-01-10

SLU Researchers Invite Living Kidney Donors and Recipients to Join NIH-Funded Study to Overcome Disparities in Kidney Disease, TransplantationJuly 24th, 2024
SSM Health Supports Living-Donor Employees With Salary BenefitApril 17th, 2023
Op-Ed: Community Invited to Engage with Researchers to Overcome Disparities in Kidney Disease and TransplantationFebruary 8th, 2023
Join now to see all

Reducing Geographic Disparity In Transplant ACCESS: Clinical And Economic ImpactNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
Cardiovascular Risk Prediction After Kidney TransplantNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010